NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,873 | +2.1% | 2,374 | +1.1% | 0.03% | +3.7% |
| Q2 2023 | $236,895 | +10.0% | 2,348 | +0.3% | 0.03% | -3.6% |
| Q1 2023 | $215,425 | +3.2% | 2,341 | +1.8% | 0.03% | -3.4% |
| Q4 2022 | $208,709 | -0.1% | 2,300 | -7.0% | 0.03% | 0.0% |
| Q2 2022 | $209,000 | -2.8% | 2,473 | +1.1% | 0.03% | +7.4% |
| Q1 2022 | $215,000 | 0.0% | 2,447 | -0.4% | 0.03% | +3.8% |
| Q4 2021 | $215,000 | -2.7% | 2,457 | -9.2% | 0.03% | -13.3% |
| Q3 2021 | $221,000 | +2.8% | 2,705 | +14.6% | 0.03% | -26.8% |
| Q2 2021 | $215,000 | +2.4% | 2,361 | -4.2% | 0.04% | -4.7% |
| Q1 2021 | $210,000 | -5.8% | 2,465 | +5.1% | 0.04% | -17.3% |
| Q4 2020 | $223,000 | +9.9% | 2,346 | 0.0% | 0.05% | -5.5% |
| Q3 2020 | $203,000 | -3.8% | 2,346 | -3.1% | 0.06% | -12.7% |
| Q2 2020 | $211,000 | -6.2% | 2,422 | -7.6% | 0.06% | -12.5% |
| Q4 2018 | $225,000 | – | 2,621 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |